GSK’s Shingrix prefilled syringe presentation approved in Canada GSK Canada announced that Health Canada has approved a prefilled syringe presentation of Shingrix (Recombinant Zoster Vaccine) fo...
CDA-AMC recommends public reimbursement of LEQEMBI (lecanemab) for early Alzheimer’s disease Eisai Canada announced that Canada’s Drug Agency (CDA-AMC) has issued a positive recommendation...
Clinuvel’s Scenesse (afamelanotide) approved in Canada for erythropoietic protoporphyria Health Canada has approved Clinuvel’s Scenesse (afamelanotide) for the prevention of phototoxicity ...
Join thousands of pharmaceutical professionals, researchers, and healthcare leaders who rely on The Pharma Canada Newsletter for the most important industry updates, delivered straight to their inbox....
